Mixed
Person-specific characteristics (genetic, hormonal, psychosocial, and behavioral) significantly predict individual variability in weight loss response to obesity interventions, making precision medicine strategies potentially more effective than broad application of treatments.
Stop assuming a single diet or exercise plan works for everyone. Your body's unique genetics, hormones, and psychology dictate how you respond to treatment. Instead of blindly following a generic plan, look for early signs of response (like weight loss in the first few weeks) to decide whether to continue or switch strategies. If you have specific genetic conditions (like leptin deficiency), targeted medical therapies may be available, but for most, success depends on matching the intervention to your specific biological and psychological profile.
Person-specific characteristics likely play a significant role in this heterogeneity in treatment response. The practice of precision medicine accounts for an individual’s genes, environment, and lifestyle when deciding upon treatment type and intensity in order to optimize benefit and minimize risk.
Why this rating
The paper is a review of multiple RCTs, cohort studies, and observational studies, providing a high level of evidence for the existence of predictors, though specific predictive models are not yet standardized.
Source
Precision medicine in adult and pediatric obesity: a clinical perspective
Eric M. Bomberg et al. · Therapeutic Advances in Endocrinology and Metabolism · 2019
DOI 10.1177/2042018819863022
More from this paper
- Early weight loss (e.g., >= 5% at 3-4 months) is a strong predictor of sustained long-term weight loss across various obesity interventions, including pharmacotherapy and lifestyle modification.Strong
- Higher baseline levels of inflammation (indicated by insulin, IL-6, adipose tissue inflammation, cortisol, and leptin) are associated with a worse weight loss response to lifestyle modification therapy.Good
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →